tiprankstipranks
AXIM Biotechnologies Inc (AXIM)
OTHER OTC:AXIM
US Market
AXIM
AXIM Biotechnologies
RESEARCH TOOLSreports
Want to see AXIM full AI Analyst Report?

AXIM Biotechnologies (AXIM) Income Statement

151 Followers

AXIM Biotechnologies Income Statement

Last quarter (Q2 2025), AXIM Biotechnologies's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, AXIM Biotechnologies's net income was $135.92K. See AXIM Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 70.46K$ 39.52K$ 8.88K$ 60.46K
Gross Profit
$ -427.37K$ -369.27K$ 39.52K$ -417.25K$ 60.46K
Operating Expenses
$ 892.28K$ 1.39M$ 2.79M$ 4.66M$ 7.79M
Depreciation and Amortization
$ 427.37K$ 432.39K$ 427.02K$ 426.13K$ 2.12M
EBITDA
$ -892.28K$ -2.44M$ -6.43M$ -3.94M$ -13.17M
Operating Income
$ -1.32M$ -1.76M$ -2.75M$ -4.65M$ -7.99M
Other Income/Expenses
$ 276.57K$ -1.75M$ -5.31M$ -1.59M$ -2.05M
Pretax Income
$ -1.04M$ -3.51M$ -8.06M$ -6.24M$ -16.02M
Net Income
$ -1.04M$ -3.51M$ -8.06M$ -5.96M$ -16.52M
Per Share Metrics
Basic EPS
$ >-0.01$ -0.01$ -0.04$ -0.04$ -0.13
Diluted EPS
$ >-0.01$ -0.01$ -0.04$ -0.04$ -0.13
Weighted Average Shares Outstanding
 340.46M 318.90M 227.69M 165.47M 131.54M
Weighted Average Shares Outstanding (Diluted)
 340.46M 318.90M 227.69M 165.47M 131.54M
Currency in USD

AXIM Biotechnologies Earnings and Revenue History